REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 170 filers reported holding REGENXBIO INC in Q1 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,421,177 | -39.7% | 121,468 | +8.6% | 0.00% | -100.0% |
| Q1 2024 | $2,356,469 | +19.2% | 111,840 | +1.5% | 0.00% | 0.0% |
| Q4 2023 | $1,977,695 | +9.2% | 110,178 | +0.1% | 0.00% | 0.0% |
| Q3 2023 | $1,811,489 | -16.7% | 110,054 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $2,173,493 | +2.6% | 108,729 | -2.9% | 0.00% | 0.0% |
| Q1 2023 | $2,117,865 | -17.5% | 111,997 | -1.0% | 0.00% | 0.0% |
| Q4 2022 | $2,565,630 | -12.1% | 113,123 | +2.5% | 0.00% | 0.0% |
| Q3 2022 | $2,918,000 | +9.0% | 110,403 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $2,677,000 | -25.7% | 108,357 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $3,601,000 | +1.1% | 108,504 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $3,563,000 | -19.4% | 108,954 | +3.3% | 0.00% | 0.0% |
| Q3 2021 | $4,420,000 | +21.1% | 105,424 | +12.2% | 0.00% | 0.0% |
| Q2 2021 | $3,651,000 | -8.2% | 93,975 | -19.4% | 0.00% | 0.0% |
| Q1 2021 | $3,977,000 | -11.5% | 116,593 | +17.6% | 0.00% | -50.0% |
| Q4 2020 | $4,496,000 | +65.5% | 99,112 | +0.4% | 0.00% | +100.0% |
| Q3 2020 | $2,717,000 | -28.7% | 98,720 | -4.5% | 0.00% | -50.0% |
| Q2 2020 | $3,809,000 | +22.2% | 103,421 | +7.5% | 0.00% | 0.0% |
| Q1 2020 | $3,116,000 | -20.4% | 96,220 | +0.7% | 0.00% | 0.0% |
| Q4 2019 | $3,916,000 | +28.9% | 95,587 | +12.0% | 0.00% | 0.0% |
| Q3 2019 | $3,038,000 | -27.4% | 85,349 | +4.7% | 0.00% | 0.0% |
| Q2 2019 | $4,187,000 | -9.9% | 81,519 | +0.5% | 0.00% | -33.3% |
| Q1 2019 | $4,647,000 | +51.2% | 81,085 | +10.4% | 0.00% | +50.0% |
| Q4 2018 | $3,073,000 | -41.8% | 73,422 | +5.0% | 0.00% | -50.0% |
| Q3 2018 | $5,281,000 | +37.8% | 69,908 | +30.9% | 0.00% | +33.3% |
| Q2 2018 | $3,831,000 | +2355.8% | 53,386 | +919.6% | 0.00% | – |
| Q1 2018 | $156,000 | -31.9% | 5,236 | -23.7% | 0.00% | – |
| Q4 2017 | $229,000 | -3.8% | 6,866 | -4.9% | 0.00% | – |
| Q3 2017 | $238,000 | +73.7% | 7,220 | +5.1% | 0.00% | – |
| Q2 2017 | $137,000 | +44.2% | 6,870 | +41.4% | 0.00% | – |
| Q1 2017 | $95,000 | +8.0% | 4,859 | +2.0% | 0.00% | – |
| Q4 2016 | $88,000 | +76.0% | 4,766 | +31.8% | 0.00% | – |
| Q3 2016 | $50,000 | +72.4% | 3,617 | 0.0% | 0.00% | – |
| Q2 2016 | $29,000 | – | 3,617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 743,079 | $14,854,149 | 9.91% |
| Aquilo Capital Management, LLC | 870,114 | $17,393,579 | 9.64% |
| MPM BioImpact LLC | 656,718 | $13,127,793 | 2.64% |
| ArchPoint Investors | 224,278 | $4,483,317 | 1.73% |
| Redmile Group, LLC | 2,026,576 | $40,511,254 | 1.56% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 35,396 | $707,566 | 1.36% |
| WS MANAGEMENT LLLP | 795,778 | $15,907,602 | 1.33% |
| Redwood Wealth Management Group, LLC | 14,760 | $295,052 | 0.33% |
| SummerHaven Investment Management, LLC | 21,298 | $425,747 | 0.27% |
| HARBOR CAPITAL ADVISORS, INC. | 44,106 | $881,679 | 0.18% |